![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 10
2022
Nitz, Ulrike A.; Gluz, Oleg; Kümmel, Sherko; Christgen, Matthias; Braun, Michael; Aktas, Bahriye; Lüdtke-Heckenkamp, Kerstin; Forstbauer, Helmut; Grischke, Eva-Maria; Schumacher, Claudia; Darsow, Maren; Krauss, Katja; Nuding, Benno; Thill, Marc; Potenberg, Jochem; Uleer, Christoph; Warm, Mathias; Fischer, Hans Holger; Malter, Wolfram; Hauptmann, Michael; Kates, Ronald E.; Gräser, Monika; Würstlein, Rachel; Shak, Steven; Baehner, Frederick; Kreipe, Hans H. und Harbeck, Nadia
(2022):
Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance in HR+/HP2-Early Breast Cancer.
In: Journal of Clinical Oncology, Bd. 40, Nr. 23: S. 2557-2567
2021
Wuerstlein, Rachel; Harbeck, Nadia; Grischke, Eva-Maria; Forstmeyer, Dirk; Schumann, Raquel von; Krabisch, Petra; Ludtke-Heckenkamp, Kerstin; Stefek, Andrea; Stoetzer, Oliver; Grafe, Andrea; Kaltenecker, Gabriele; Forstbauer, Helmut; Augustin, Doris; Schrader, Iris; Tio, Joke; Nitz, Ulrike; Gluz, Oleg; Kates, Ronald E. und Graeser, Monika Karla
(2021):
Protroca: A Noninterventional Study on Prophylactic Lipegfilgrastim against Chemotherapy-Induced Neutropenia in Nonselected Breast Cancer Patients.
In: Breast Care, Bd. 16, Nr. 1: S. 50-58
2020
Christgen, Matthias; Gluz, Oleg; Harbeck, Nadia; Kates, Ronald E.; Raap, Mieke; Christgen, Henriette; Clemens, Michael; Malter, Wolfram; Nuding, Benno; Aktas, Bahriye; Kuemmel, Sherko; Reimer, Toralf; Stefek, Andrea; Krabisch, Petra; Just, Marianne; Augustin, Doris; Graeser, Monika; Baehner, Frederick; Würstlein, Rachel; Nitz, Ulrike und Kreipe, Hans
(2020):
Differential impact of prognostic parameters in hormone receptor-positive lobular breast cancer.
In: Cancer, Bd. 126, Nr. 22: S. 4847-4858
Kolberg-Liedtke, Cornelia; Würstlein, Rachel; Gluz, Oleg; Heitz, Florian; Freudenberger, Muriel; Bensmann, Elena; du Bois, Andreas; Nitz, Ulrike; Pelz, Enrico; Warm, Matthias; Ortmann, Monika; Sultova, Elena; Brucker, Sara Y.; Kates, Ronald E.; Fehm, Tanja und Harbeck, Nadia
(2020):
Phenotype Discordance between Primary Tumor and Metastasis Impacts Metastasis Site and Outcome: Results of WSG-DETECT-PriMet.
In: Breast Care
Nitz, Ulrike; Gluz, Oleg; Kreipe, Hans H.; Christgen, Matthias; Kuemmel, Sherko; Baehner, Frederick L.; Shak, Steven; Aktas, Bahriye; Braun, Michael; Ludtke-Heckenkamp, Kerstin; Forstbauer, Helmut; Grischke, Eva-Maria; Nuding, Benno; Darsow, Maren; Schumacher, Claudia; Krauss, Katja; Malter, Wolfram; Thill, Marc; Warm, Mathias; Würstlein, Rachel; Kates, Ronald E. und Harbeck, Nadia
(2020):
The run-in phase of the prospective WSG-ADAPT HR+/HER2-trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer.
In: Therapeutic Advances in Medical Oncology, Bd. 12: S. 1-9
[PDF, 531kB]
2019
Nitz, Ulrike; Gluz, Oleg; Clemens, Michael; Malter, Wolfram; Reimer, Toralf; Nuding, Benno; Aktas, Bahriye; Stefek, Andrea; Pollmanns, Anke; Lorenz-Salehi, Fatemeh; Uleer, Christoph; Krabisch, Petra; Kümmel, Sherko; Liedtke, Cornelia; Shak, Steven; Wuerstlein, Rachel; Christgen, Matthias; Kates, Ronald E.; Kreipe, Hans H.; Harbeck, Nadia; Ackermann, S.; Aktas, B.; Augustin, D.; Baake, G.; Baumann, K.; Berger, R.; Bettscheider, J.; Bischoff, J.; Clemens, M.; Deryal, M.; Dubbers, H.; Duchting, D.; Dunnebacke, J.; Fett, W.; Fietz, T.; Fischer, H.; Forner, M.; Forstbauer, H.; Freese, K.; Geberth, M.; Glados, M.; Gnauert, K.; Goette, O.; Gohring, U.; Goppinger, A.; Grafe, A.; Hackenberg, R.; Hackmann, J.; Hellriegel, M.; Heyl, V.; Hoestermann, C.; Hoffmann, G.; Hofmann, M.; Hucke, J.; Jackisch, C.; Jungberg, P.; Just, M.; Kahl, C.; Klare, P.; Kogel, M.; Kohls, A.; Amrawy, B. Konigs-El; Konnecke, P.; Krabisch, P.; Kraudelt, S.; Kremers, S.; Kummel, S.; Kurbacher, C.; Kusche, J.; Liedtke, B.; Liedtke, C.; Link, H.; Lorenz, R.; Salehi, F. Lorenz; Lubbe, K.; Malter, W.; Melekian, B.; Mobus, V.; Montenarh, M.; Müller, V.; Mundhenke, C.; Niederle, N.; Nitz, U.; Noesselt, T.; Oberhoff, C.; Paas, L.; Paepke, S.; Pollmanns, A.; Reichert, D.; Reimer, T.; Romann, D.; Ruhland, T.; Runde, V.; Salem, M.; Schlosser, A.; Schneider, A.; Schrader, I.; Schulz, H.; Schumacher, C.; Schwickerath, J.; Soling, U.; Stauder, H.; Stefek, A.; Steinmetz, T.; Stickeler, E.; Terhaag, J.; Thomssen, C.; Tome, O.; Uleer, C.; Warm, M.; Wachsmann, G.; Wacker, J.; Wiebringhaus, H.; Wiest, W.; Wolfgarten, M.; Nitz, U.; Christgen, H.; Kreipe, H.; Buehne, C.; Gluz, O.; Hansen, K.; Hofmann, D.; Kates, R.; Mangold, M.; Mathissen, M.; Raeth, P.; Renner, I.; Reiser, I.; Schumacher, J.; Staedele, M. und Walter-Kirst, R.
(2019):
West German Study PlanB Trial: Adjuvant Four Cycles of Epirubicin and Cyclophosphamide Plus Docetaxel Versus Six Cycles of Docetaxel and Cyclophosphamide in HER2-Negative Early Breast Cancer.
In: Journal of Clinical Oncology, Bd. 37, Nr. 10
2017
Nitz, Ulrike; Gluz, Oleg; Christgen, Matthias; Kates, Ronald E.; Clemens, Michael; Malter, Wolfram; Nuding, Benno; Aktas, Bahriye; Kümmel, Sherko; Reimer, Toralf; Stefek, Andrea; Lorenz-Salehi, Fatemeh; Krabisch, Petra; Just, Marianne; Augustin, Doris; Liedtke, Cornelia; Chao, Calvin; Shak, Steven; Würstlein, Rachel; Kreipe, Hans H. und Harbeck, Nadia
(2017):
Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial.
In: Breast Cancer Research and Treatment, Bd. 165, Nr. 3: S. 573-583
2016
Gluz, Oleg; Nitz, Ulrike A.; Christgen, Matthias; Kates, Ronald E.; Shak, Steven; Clemens, Michael; Kraemer, Stefan; Aktas, Bahriye; Kuemmel, Sherko; Reimer, Toralf; Kusche, Manfred; Heyl, Volker; Lorenz-Salehi, Fatemeh; Just, Marianne; Hofmann, Daniel; Degenhardt, Tom; Liedtke, Cornelia; Svedman, Christer; Wuerstlein, Rachel; Kreipe, Hans H. und Harbeck, Nadia
(2016):
West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment.
In: Journal of Clinical Oncology, Bd. 34, Nr. 20:
2341-U66
2014
Ataseven, Beyhan; Gunesch, Angela; Eiermann, Wolfgang; Kates, Ronald E.; Högel, Bernhard; Knyazev, Pjotr; Ullrich, Axel und Harbeck, Nadia
(2014):
PTK7 as a potential prognostic and predictive marker of response to adjuvant chemotherapy in breast cancer patients, and resistance to anthracycline drugs.
In: Oncotargets and Therapy, Bd. 7: S. 1723-1731
[PDF, 668kB]
2013
Hofmann, Daniel; Nitz, Ulrike; Gluz, Oleg; Kates, Ronald E.; Schinkoethe, Timo; Staib, Peter und Harbeck, Nadia
(2013):
WSG ADAPT - adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator initiated phase II/III trial.
In: Trials
14:261
[PDF, 1MB]